9th Circuit Court Allows Lawsuit on FODMAP Labeling to Proceed, Impacting Food Industry Regulations

What's Happening?

The 9th US Circuit Court of Appeals has ruled to allow a First Amendment lawsuit challenging the federal government's ban on low-FODMAP labeling to proceed. The case, initially dismissed in 2024, was brought by Michelle Przybocki and Ketan Vakil against the USDA, FDA, and Food Safety and Inspection Service. Przybocki, who requires a low-FODMAP diet due to severe digestive issues, and Vakil, owner of Gourmend Foods, argue that the ban on labeling products as low-FODMAP infringes on free speech. Gourmend Foods, which specializes in low-FODMAP products, faced regulatory hurdles when attempting to label their beef broth as such. The appeals court's decision highlights the potential injury to both Vakil and Przybocki due to the regulations, which they claim hinder the development and marketing of new low-FODMAP products.

Why It's Important?

This ruling is significant as it addresses the intersection of food labeling regulations and free speech rights. The outcome of this case could have wide-reaching implications for the food industry, particularly for companies producing specialized dietary products. If successful, the lawsuit could lead to changes in how food products are labeled, providing consumers with more information about FODMAP levels. This could benefit millions of Americans with digestive disorders who rely on such information to manage their diets. The case also underscores the tension between regulatory agencies and businesses over the dissemination of factual product information.

What's Next?

Following the 9th Circuit's decision, the FDA and USDA have 90 days to petition the US Supreme Court to review the case. If they choose not to, the case will return to the district court to evaluate the First Amendment claims. A favorable ruling for the plaintiffs could result in a court order allowing companies to include low-FODMAP information on their labels. This would set a precedent for similar cases, potentially prompting regulatory changes and influencing how dietary information is communicated to consumers.